Trial NCT02058108

View at ClinicalTrials.gov 
Org. Study IDs: CLDT600A2306
Secondary IDs: 2012-004942-14

Last trial update was posted on 2019-09-10

MeSH Interventions

Telbivudine

MeSH Conditions

Hepatitis Hepatitis A Hepatitis B Hepatitis B, Chronic Hepatitis, Chronic Herpesviridae Infections Virus Diseases

Other Conditions

Chronic Hepatitis B

Stopping Reasons

Study terminated on the recommendation of an independent Data Monitoring Committee (DMC) subsequent to an interim efficacy analysis for futility.]

Limitations And Caveats

Due to early termination of the study and limited number of enrolled patients on track to complete 52 weeks of participation (8 patients overall), no formal analysis of Weeks 52 and 104 long-term efficacy endpoints (only descriptive analysis).

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID